510(k) Report

510(k) · Cleared

Cleared

Audit Microcv RF/CRP Linearity Set

K101226510(k) TraditionalCleared Aug 31, 2010120-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aalto Scientific, Ltd. · JJY Multi-Analyte Controls, All Kinds (Assayed)

Cleared on Aug 31, 2010 as substantially equivalent to K023661 (Cliniqa Corporation, 2002) and 2 other predicates after a 120-day review. Its family tree reaches back 3 generations to 1991.

Decided
Aug 31, 2010
Review
120 days
Class
Class I
Product code
JJY
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K910440 (1991). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK910440 Document Reflectance II Linearity Test SetCasco Standards · 1991
  2. 2 generations backK023410 Validate Chem 10 Calibration Verification Test Set, Model 110Maine Standards Co. · 2003
  3. 1 generation backK042318 Audit Microcv General Chemistry Linearity SetAalto Scientific, Ltd. · 2004
  4. This deviceK101226 Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K910440Document Reflectance II Linearity Test SetCasco Standards1991—
−2K023410Validate Chem 10 Calibration Verification Test Set, Model 110Maine Standards Co.2003—
−1K042318Audit Microcv General Chemistry Linearity SetAalto Scientific, Ltd.2004—
0 (this device)K101226Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200110
200210
FIG. 1 — Lineage of K101226, 1991–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023661Linical RF-CRP Calibration Verifiers Levels a-E for Beckman Coulter Synchron CX Systems
Summary page 1
…rade Name: LiniCAL Calibration Verifier RF/CRP CLINIQA, Fallbrook, CA 92028 K023661 Liquichek Lipids Control Bijo-Rad Laboratories, Irvi…
Cliniqa Corporation2002—
*K012513Liquichek Lipids Control Level 1, Liquichek Lipids Control Level 2, Models 641 and 642
Summary page 1
…Liquichek Lipids Control Bijo-Rad Laboratories, Irvine, California K0 125 13 Audit MicroCV General Chemistry Linearity Set Aalto…
Bio-Rad2001—
*K042318Audit Microcv General Chemistry Linearity Set
Summary page 1
…Audit MicroCV General Chemistry Linearity Set Aalto Scientific, Ltd., Carlsbad, California K042318 Page I of 4 A ~;~nSifhIL,…
Aalto Scientific, Ltd.2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 5.7 years on median.
  • None of the 6 ancestors has a recall.

How does its category compare?

All JJY devices

JJY Multi-Analyte Controls, All Kinds (Assayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JJY

3in 2017

2007: 112008: 72009: 82010: 102011: 142012: 132013: 162014: 102015: 42016: 12017: 3
2007high 16 (2013) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJY

78in 2017

2007: 49 days median2008: 54 days median2009: 80 days median2010: 109 days median2011: 120 days median2012: 40 days median2013: 82 days median2014: 49 days median2015: 153 days median2017: 78 days median
2007high 153 (2015) · low 40 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJY

2in 2025

2007: 52009: 22010: 62011: 12012: 32013: 22014: 22015: 12016: 32017: 42018: 32019: 42020: 62022: 32023: 32025: 22026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJY

13in 2025

2007: 22008: 12009: 32010: 32011: 62012: 202013: 52014: 42015: 42016: 132017: 122018: 72019: 12020: 72021: 12023: 42024: 12025: 13
2007high 20 (2012) · low 0 (2022)2025

MAUDE reports naming product code JJY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007114952
200875401
200988023
20101010963
20111412016
20121340320
2013168225
2014104924
2015415314
20161—313
2017378412
20180—37
20190—41
20200—67
20210—01
20220—30
20230—34
20240—01
20250—213
20260—1—

What is it indicated for?

The AuditTM MicroCVTM RF/CRP Linearity Set is an assayed quality control material consisting of five levels human based serum. Each level contains Rheumatoid Factor (RF) and C-Reactive Protein (CRP) analytes. The five levels demonstrate a linear relationship to each other for Rheumatoid Factor (RF) and C-Reactive Protein (CRP) analytes. This product may also be used as unassayed quality control material for Rheumatoid Factor (RF) and C-Reactive Protein…

Read the full statement (124 words)

The AuditTM MicroCVTM RF/CRP Linearity Set is an assayed quality control material consisting of five levels human based serum. Each level contains Rheumatoid Factor (RF) and C-Reactive Protein (CRP) analytes. The five levels demonstrate a linear relationship to each other for Rheumatoid Factor (RF) and C-Reactive Protein (CRP) analytes. This product may also be used as unassayed quality control material for Rheumatoid Factor (RF) and C-Reactive Protein (CRP) analytes. When used for quality control purposes, it is recommended that each laboratory establish its own means and acceptable ranges and use the values provided only as guides. The product is intended for use with quantitative assays on manual, automatic, and semi-automatic analyzers. The AuditTM MicroCVTM RF/CRP Linearity Set is "For In Vitro Diagnostic Use Only".

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101226: Audit Microcv RF/CRP Linearity Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K101226

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026